Charter Renewal for the Advisory Commission on Childhood Vaccines, 43588 [2020-15494]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
43588
Federal Register / Vol. 85, No. 138 / Friday, July 17, 2020 / Notices
the meeting is open to the public.
Interested persons may present data,
information, or views, orally or in
writing, on issues pending before the
committee. Written submissions may be
made to the contact person on or before
August 11, 2020. Oral presentations
from the public will be scheduled
between approximately 1 p.m. and 2
p.m. Those individuals interested in
making formal oral presentations should
notify the contact person and submit a
brief statement of the general nature of
the evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before August 3, 2020. Time allotted
for each presentation may be limited. If
the number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by August 4, 2020.
Closed Committee Deliberations: On
August 18, 2020, from 11:30 a.m. to 12
p.m. (CST), the meeting will be closed
to permit discussion where disclosure
would constitute a clearly unwarranted
invasion of personal privacy (5 U.S.C.
552b(c)(6)). This portion of the meeting
will be closed to permit discussion of
information concerning individuals
associated with the research programs at
the NCTR.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with disabilities.
If you require accommodations due to a
disability, please contact Donna
Mendrick at least 14 days in advance of
the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our website at
https://www.fda.gov/
AdvisoryCommittees/AboutAdvisory
Committees/ucm111462.htm for
procedures on public conduct during
advisory committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: July 14, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020–15524 Filed 7–16–20; 8:45 am]
BILLING CODE 4164–01–P
VerDate Sep<11>2014
18:12 Jul 16, 2020
Jkt 250001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Charter Renewal for the Advisory
Commission on Childhood Vaccines
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, HHS
is hereby giving notice that the Advisory
Commission on Childhood Vaccines
(ACCV) charter has been renewed. The
effective date of the renewed charter is
July 20, 2020.
FOR FURTHER INFORMATION CONTACT:
Tamara Overby, Designated Federal
Officer, Healthcare Systems Bureau,
HRSA, 5600 Fishers Lane, 08N186A,
Rockville, Maryland 20857; 301–443–
3766; or toverby@hrsa.gov.
SUPPLEMENTARY INFORMATION: The ACCV
was established by section 2119 of the
Public Health Service Act (the Act) (42
U.S.C. 300aa–19), as enacted by Public
Law (Pub. L.) 99–660, and as
subsequently amended, and advises the
Secretary of Health and Human Services
(the Secretary) on issues related to the
implementation of the National Vaccine
Injury Compensation Program (VICP).
Other activities of the ACCV include:
Recommending changes in the Vaccine
Injury Table at its own initiative or as
the result of the filing of a petition;
advising the Secretary in implementing
section 2127 of the Act regarding the
need for childhood vaccination
products that result in fewer or no
significant adverse reactions; surveying
federal, state, and local programs and
activities related to gathering
information on injuries associated with
the administration of childhood
vaccines, including the adverse reaction
reporting requirements of section
2125(b) of the Act; advising the
Secretary on the methods of obtaining,
compiling, publishing, and using
credible data related to the frequency
and severity of adverse reactions
associated with childhood vaccines;
consulting on the development or
revision of Vaccine Information
Statements; and recommending to the
Director of the National Vaccine
Program research related to vaccine
injuries which should be conducted to
carry out the VICP.
The renewed charter for the ACCV
was approved on July 20, 2020, which
will also stand as the filing date.
Renewal of the ACCV charter gives
SUMMARY:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
authorization for the commission to
operate until July 20, 2022.
A copy of the ACCV charter is
available on the ACCV’s website at
https://www.hrsa.gov/advisorycommittees/vaccines/. A
copy of the charter also can be obtained
by accessing the FACA database that is
maintained by the Committee
Management Secretariat under the
General Services Administration. The
website address for the FACA database
is https://www.facadatabase.gov/.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020–15494 Filed 7–16–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on HIV/AIDS
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice of a virtual meeting.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Service is hereby giving notice that the
Presidential Advisory Council on HIV/
AIDS (PACHA or the Council) will be
holding the 68th full Council meeting
utilizing virtual technology. PACHA
members will be discussing novel
coronavirus (COVID–19) and HIV, and
Ready, Set, PrEP enrollment. The
meeting will be open to the public; a
public comment session will be held
during the meeting. Pre-registration is
required to provide public comment.
DATES: The meeting will be held on
Thursday, August 6, from
approximately 3:00 p.m. to 5:00 p.m.
(ET). This meeting will be conducted
utilizing virtual technology.
ADDRESSES: Instructions regarding
attending this meeting virtually will be
posted one week prior to the meeting at:
https://www.hiv.gov/federal-response/
pacha/about-pacha.
FOR FURTHER INFORMATION CONTACT: Ms.
Caroline Talev, MPA, Public Health
Analyst, Presidential Advisory Council
on HIV/AIDS, 330 C Street SW, Room
L609A, Washington, DC 20024; (202)
795–7622 or PACHA@hhs.gov.
Additional information can be obtained
by accessing the Council’s page on the
HIV.gov site at www.hiv.gov/pacha.
SUPPLEMENTARY INFORMATION:
Individuals who wish to participate in
the meeting and/or provide public
SUMMARY:
E:\FR\FM\17JYN1.SGM
17JYN1
]]>Agencies
[Federal Register Volume 85, Number 138 (Friday, July 17, 2020)]
[Notices]
[Page 43588]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-15494]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Charter Renewal for the Advisory Commission on Childhood Vaccines
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, HHS is
hereby giving notice that the Advisory Commission on Childhood Vaccines
(ACCV) charter has been renewed. The effective date of the renewed
charter is July 20, 2020.
FOR FURTHER INFORMATION CONTACT: Tamara Overby, Designated Federal
Officer, Healthcare Systems Bureau, HRSA, 5600 Fishers Lane, 08N186A,
Rockville, Maryland 20857; 301-443-3766; or [email protected].
SUPPLEMENTARY INFORMATION: The ACCV was established by section 2119 of
the Public Health Service Act (the Act) (42 U.S.C. 300aa-19), as
enacted by Public Law (Pub. L.) 99-660, and as subsequently amended,
and advises the Secretary of Health and Human Services (the Secretary)
on issues related to the implementation of the National Vaccine Injury
Compensation Program (VICP). Other activities of the ACCV include:
Recommending changes in the Vaccine Injury Table at its own initiative
or as the result of the filing of a petition; advising the Secretary in
implementing section 2127 of the Act regarding the need for childhood
vaccination products that result in fewer or no significant adverse
reactions; surveying federal, state, and local programs and activities
related to gathering information on injuries associated with the
administration of childhood vaccines, including the adverse reaction
reporting requirements of section 2125(b) of the Act; advising the
Secretary on the methods of obtaining, compiling, publishing, and using
credible data related to the frequency and severity of adverse
reactions associated with childhood vaccines; consulting on the
development or revision of Vaccine Information Statements; and
recommending to the Director of the National Vaccine Program research
related to vaccine injuries which should be conducted to carry out the
VICP.
The renewed charter for the ACCV was approved on July 20, 2020,
which will also stand as the filing date. Renewal of the ACCV charter
gives authorization for the commission to operate until July 20, 2022.
A copy of the ACCV charter is available on the ACCV's website at
https://www.hrsa.gov/advisory-committees/vaccines/. A copy of
the charter also can be obtained by accessing the FACA database that is
maintained by the Committee Management Secretariat under the General
Services Administration. The website address for the FACA database is
https://www.facadatabase.gov/.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020-15494 Filed 7-16-20; 8:45 am]
BILLING CODE 4165-15-P
